| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.074 | 12.787 | 22.082 | 20.699 | 16.516 | 15.089 | 15.117 | 44.134 | 18.684 | 43.361 |
| Total Income - EUR | 4.074 | 12.787 | 22.082 | 20.700 | 16.517 | 15.091 | 15.118 | 44.141 | 42.972 | 43.395 |
| Total Expenses - EUR | 3.856 | 7.639 | 15.347 | 24.047 | 19.719 | 17.648 | 19.096 | 25.241 | 25.595 | 28.172 |
| Gross Profit/Loss - EUR | 217 | 5.148 | 6.735 | -3.347 | -3.202 | -2.557 | -3.979 | 18.900 | 17.378 | 15.223 |
| Net Profit/Loss - EUR | 95 | 4.892 | 6.514 | -3.555 | -3.367 | -2.790 | -3.981 | 18.598 | 17.191 | 14.484 |
| Employees | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Montana Biovet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 821 | 660 | 1.958 |
| Current Assets | 1.591 | 5.774 | 12.819 | 9.452 | 5.470 | 4.455 | 4.065 | 21.939 | 36.101 | 45.422 |
| Inventories | 33 | 200 | 797 | 2.331 | 775 | 511 | 619 | 149 | 732 | 511 |
| Receivables | 0 | 189 | 7.111 | 4.837 | 796 | 1.236 | 0 | 3 | 0 | 4.392 |
| Cash | 1.558 | 5.385 | 4.910 | 2.284 | 3.899 | 2.707 | 3.445 | 21.787 | 35.370 | 40.519 |
| Shareholders Funds | 353 | 5.242 | 11.668 | 7.899 | 4.379 | 1.506 | -2.509 | 16.082 | 33.223 | 43.100 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.238 | 533 | 1.151 | 1.553 | 1.091 | 2.949 | 6.574 | 6.678 | 3.538 | 4.281 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Montana Biovet S.r.l.